Detecting the levels of amino acids and carnitine in the blood of newborns can screen for the presence of genetic metabolic diseases included in newborns
Disease prevention is preventive measures against pathogenic factors through early detection and early diagnosis and appropriate treatment
New medical services to assess health status and risk factors affecting health, and promote health for everyone
Since its establishment, Yingsheng Biological has been mainly engaged in independent research and development, production and sales of in vitro diagnostic reagents and medical equipment.
Therapeutic drug monitoring (TDM) is to determine the drug exposure, pharmacological markers or efficacy indicators...
Neonatal genetic and metabolic disease screening refers to the population census, early detection and early treatme...
Mass spectrometry technology is widely used in chemistry, chemical industry, environment, energy, medicine, sports m...
It is the most common defect of the human sensory and acoustic nervous system caused by the genetic material of...
On April 8, 2021, the 3rd World Health Expo opened at Wuhan International Expo Center With the theme of "Healthy Community, Technology Creates the Future", the main venue set up 12 professional exhibition areas including international healthcare, medi
Recently, Shandong Yingsheng Biotechnology Co , Ltd completed Series B financing of several hundred million yuan, which was led by Gaochun Venture Capital Old shareholders such as Chenling Capital, Sunshine Ronghui Capital, Huimei Capital and Qianhai Parent F
On the morning of July 26th, the 12th annual economic figures selection and awards event was held in Long & 39;ao Building Sun Licheng, member of the Standing Committee of Shandong Provincial Party Committee and secretary of Jinan Municipal Party Committee,